Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...
ACS's goal is to survey 100,000 Black women between ages 25 and 55 who have not had a cancer diagnosis across the U.S. to increase understanding of Black women's health amid sharp racial health ...
East Harris County has elevated levels of cervix uteri, leukemia, lung and bronchus, and lymphoma cancers, the Texas ...
Laura Wharam thought she had appendicitis but her breast cancer had returned and metastasized, spreading to her liver, bones, ...
Higher TIL levels predict better survival in early ERBB2-positive breast cancer, supporting treatment de-escalation for select patients.
More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...
Lack of screening and limited treatment options mean that low- and middle-income countries face higher death rates despite ...
After battling cancer and learning about harmful ingredients, Emily Phillips, 35, changed her diet completely. But what do oncology experts think?
The review found that previous research often grouped black women from diverse backgrounds together, including black African and black Caribbean, masking important cultural nuance ...
5d
Hosted on MSNAstraZeneca Rises Almost 9% in a Month: How to Play the StockAstraZeneca AZN stock has risen 8.6% in the past month, mainly due to mixed fourth-quarter results and a positive update from ...
Dr. Debu Tripathy breaks down the FDA approval of Enhertu in unresectable or metastatic HR-positive, HER2-low or -ultralow ...
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results